Capecitabine and Death - a phase IV clinical study of FDA data
Summary:
Death is reported as a side effect among people who take Capecitabine (capecitabine), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Oxaliplatin, and have Colon cancer.
The study is created by eHealthMe based on reports of 59,451 people who have side effects when taking Capecitabine from the FDA, and is updated regularly.
What is Capecitabine?
Capecitabine has active ingredients of capecitabine. eHealthMe is studying from 59,495 Capecitabine users. Check the latest studies of Capecitabine.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
59,451 people reported to have side effects when taking Capecitabine.
Among them, 5,023 people (8.45%) died.
Among these 5,023 people:
How long have people been on Capecitabine when they died? *
What is the gender of people who died when taking Capecitabine? *
What is the age of people who died when taking Capecitabine? *
What are other drugs people take besides Capecitabine? *
What are other side effects people have before they died? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Capecitabine:
- Capecitabine (59,495 reports)
Expand to all the drugs that have ingredients of capecitabine:
- Death and drugs with ingredients of capecitabine (10,300 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Capecitabine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Death:
- Death (3,108 drugs)
Browse all the conditions that are associated with Death:
- Death (3,686 conditions)
Related publications that referenced our studies
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on capecitabine (the active ingredients of Capecitabine) and Capecitabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Hydrocortisone Sodium Succinate cause Mucosal Inflammation? - 2 seconds ago
- Could Wellbutrin cause Malignant Melanoma? - 5 seconds ago
- Could Wellbutrin cause Haemorrhoids Aggravated? - 6 seconds ago
- Prevacid and Restlessness for Boys aged 2-9 - 8 seconds ago
- Prevacid and Agitation for Boys aged 2-9 - 8 seconds ago
- Progesterone and Hair Loss for Women aged 60+ - 16 seconds ago
- Progesterone and Hair Thinning for Women aged 60+ - 16 seconds ago
- Progesterone and Loss Of Hair for Women aged 60+ - 16 seconds ago
- Progesterone and Hairloss for Women aged 60+ - 16 seconds ago
- Progesterone and Alopecia for Women aged 60+ - 17 seconds ago